David Mannino, MD, an expert in chronic obstructive pulmonary disease (COPD) from the University of Kentucky College of Medicine and co-founder of the COPD Foundation, discusses the most clinically relevant data presented at the American Thoracic Society 2021 International Conference.
He begins with a study comparing the impact of COVID-19 on outcomes in patients with and without COPD and/or emphysema, which offered reassuring results.
Next, he looks at the safety and clinical utility of a novel technology, bronchial rheoplasty, that delivers nonthermal pulsed electric fields to the airway epithelium and submucosa.
He then reports on a study assessing the accuracy of machine learning to identify the primary drivers of progression, exacerbation, and COPD mortality among cases in a large patient database.
Finally, Dr Mannino turns to the socioeconomic aspect of COPD management, discussing first a study on the availability of pulmonary rehabilitation among Medicare beneficiaries, followed by an analysis of the presence of indicators of financial, food, and housing insecurity among COPD patients.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: COPD Highlights From ATS 2021 - Medscape - Jun 09, 2021.
Comments